Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark N Prichard

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Reviews in Medical Virology|May 13, 2009
Function of human cytomegalovirus UL97 kinase in viral infection and its inhibition by maribavirMark N Prichard
Antiviral Research|March 13, 2012
Orthopoxvirus targets for the development of new antiviral agentsMark N Prichard, Earl R Kern
Antiviral Research|July 6, 2017
Comparison of three dimensional synergistic analyses of percentage versus logarithmic data in antiviral studiesDonald F Smee, Mark N Prichard
Current Drug Targets. Infectious Disorders|March 22, 2005
Orthopoxvirus targets for the development of antiviral therapiesMark N Prichard, Earl R Kern
Virus Research|November 25, 2010
The search for new therapies for human cytomegalovirus infectionsMark N Prichard, Earl R Kern
Antiviral Research|September 19, 2018
New therapies for human cytomegalovirus infectionsWilliam J Britt, Mark N Prichard
Current Opinion in Virology|December 14, 2011
Progress in the development of new therapies for herpesvirus infectionsNathan B Price, Mark N Prichard
Current Opinion in Virology|December 3, 2014
The development of new therapies for human herpesvirus 6Mark N Prichard, Richard J Whitley
Viruses|October 14, 2011
Antiviral Activity of 4'-thioIDU and Thymidine Analogs against OrthopoxvirusesMark N Prichard, Earl R Kern
Current Opinion in Virology|July 19, 2014
Current and future therapies for herpes simplex virus infections: mechanism of action and drug resistanceScott H James, Mark N Prichard
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Reviews in Medical Virology|May 13, 2009
Function of human cytomegalovirus UL97 kinase in viral infection and its inhibition by maribavirMark N Prichard
Antiviral Research|March 13, 2012
Orthopoxvirus targets for the development of new antiviral agentsMark N Prichard, Earl R Kern
Antiviral Research|July 6, 2017
Comparison of three dimensional synergistic analyses of percentage versus logarithmic data in antiviral studiesDonald F Smee, Mark N Prichard
Current Drug Targets. Infectious Disorders|March 22, 2005
Orthopoxvirus targets for the development of antiviral therapiesMark N Prichard, Earl R Kern
Virus Research|November 25, 2010
The search for new therapies for human cytomegalovirus infectionsMark N Prichard, Earl R Kern
Antiviral Research|September 19, 2018
New therapies for human cytomegalovirus infectionsWilliam J Britt, Mark N Prichard
Current Opinion in Virology|December 14, 2011
Progress in the development of new therapies for herpesvirus infectionsNathan B Price, Mark N Prichard
Current Opinion in Virology|December 3, 2014
The development of new therapies for human herpesvirus 6Mark N Prichard, Richard J Whitley
Viruses|October 14, 2011
Antiviral Activity of 4'-thioIDU and Thymidine Analogs against OrthopoxvirusesMark N Prichard, Earl R Kern
Current Opinion in Virology|July 19, 2014
Current and future therapies for herpes simplex virus infections: mechanism of action and drug resistanceScott H James, Mark N Prichard
Pageof 8